Ventricular dysfunction and the risk of stroke after myocardial infarction

New England Journal of Medicine

Volumn 336, Issue 4, 1997, Pages 251-257

  Loh, Evan ^a   Sutton, Martin St John ^a   Wun, Chuan Chuan C ^b   Rouleau, Jean L ^c   Flaker, Greg C ^d   Gottlieb, Stephen S ^e   Lamas, Gervasio A ^f   Moyé, Lemuel A ^b   Goldhaber, Samuel Z ^g   Pfeffer, Marc A ^g  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c MONTREAL HEART INSTITUTE   (Canada)

^d UNIVERSITY OF MISSOURI   (United States)

^e UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^f MOUNT SINAI MEDICAL CENTER   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CAPTOPRIL; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STROKE;

ADULT; AGED; CEREBROVASCULAR DISORDERS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 1842295207     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199701233360403     Document Type: Article

References (34)

1. Prospective Studies Collaboration. Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts. Lancet 1995;346:1647-53.
2. Maggioni AP, Franzosi MG, Santoro E, et al. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. N Engl J Med 1992;327:1-6.
3. Hess DC, D'Cruz IA, Adams RJ, Nichols FT III. Coronary artery disease, myocardial infarction, and brain embolism. Neurol Clin 1993;11: 399-417.
4. Behar S, Tanne D, Abinader E, et al. Cerebrovascular accident complicating acute myocardial infarction: incidence, clinical significance, and short-and long-term mortality rates. Am J Med 1991;91:45-50.
5. Maggioni AP, Franzosi MG, Farina ML, et al. Cerebrovascular events after myocardial infarction: analysis of the GISSI trial. BMJ 1991;302: 1428-31.
6. Thompson PL, Robinson JS. Stroke after acute myocardial infarction: relation to infarct size. BMJ 1978;2:457-9.
7. Komrad MS, Coffey CE, Coffey KS, McKinnis R, Massey EW, Califf RM. Myocardial infarction and stroke. Neurology 1984;34:1403-9.
8. Johannessen KA, Nordrehaug JE, von der Lippe G. Left ventricular thrombosis and cerebrovascular accident in acute myocardial infarction. Br Heart J 1984;51:533-6.
9. Lamas GA, Vaughan DE, Pfeffer MA. Left ventricular thrombus formation after first anterior wall acute myocardial infarction. Am J Cardiol 1988;62:31-5.
10. Weinreich DJ, Burke JF, Pauletto FJ. Left ventricular mural thrombi complicating acute myocardial infarction: long term follow-up with serial echocardiography. Ann Intern Med 1984;100:789-94.
11. Keating EC, Gross SA, Schlamowitz RA, et al. Mural thrombi in myocardial infarctions: prospective evaluation by two-dimensional echocardiography. Am J Med 1983;74:989-95.
12. Vaitkus P, Barnathan ES. Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: a meta-analysis. J Am Coll Cardiol 1993;22:1004-9.
13. Domenicucci S, Bellotti P, Chiarella F, Lupi G, Vecchio C. Spontaneous morphologic changes in left ventricular thrombi: a prospective two-dimensional echocardiographic study. Circulation 1987;75:737-43.
14. Visser CA, Kan G, Meltzer RS, Lie KI, Durrer D. Long-term follow-up of left ventricular thrombus after acute myocardial infarction: a two-dimensional echocardiographic study in 96 patients. Chest 1984;86:532-6.
15. Stratton JR, Nemanich JW, Johannessen KA, Resnick AD. Fate of left ventricular thrombi in patients with remote myocardial infarction or idiopathic cardiomyopathy. Circulation 1988;78:1388-93.
16. Ciaccheri M, Castelli G, Cecchi F, et al. Lack of correlation between intracavitary thrombosis detected by cross sectional echocardiography and systemic emboli in patients with dilated cardiomyopathy. Br Heart J 1989; 62:26-9.
17. Asinger RW, Mikell FL, Elsperger J, Hodges M. Incidence of left-ventricular thrombosis after acute transmural myocardial infarction: serial evaluation by two-dimensional echocardiography. N Engl J Med 1981;305: 297-302.
18. Friedman MJ, Carlson K, Marcus FI, Woolfenden JM. Clinical correlations in patients with acute myocardial infarction and left ventricular thrombus detected by two-dimensional echocardiography. Am J Med 1982;72:894-8.
19. Martin R, Bogousslavsky J. Mechanism of late stroke after myocardial infarct: the Lausanne Stroke Registry. J Neurol Neurosurg Psychiatry 1993;56:760-4.
20. Pfeffer MA, Braunwald E, Moyé LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992;327:669-77.
21. Segal JP, Stapleton JF, McClellan JR, Waller BF, Harvey WP. Idiopathic cardiomyopathy: clinical features, prognosis and therapy. Curr Probl Cardiol 1978;3:1-48.
22. Tanne D, Reicher-Reiss H, Boyko V, Behar S. Stroke risk after anterior wall acute myocardial infarction. Am J Cardiol 1995;76:825-6.
23. Kyrie PA, Korninger C, Gössinger H, et al. Prevention of arterial and pulmonary embolism by oral anticoagulants in patients with dilated cardiomyopathy. Thromb Haemost 1985;54:521-3.
24. Dunkman WB, Johnson GR, Carson PE, Bhat G, Farrell L, Cohn JN. Incidence of thromboembolic events in congestive heart failure Circulation 1993;87:Suppl VI:VI-94-VI-101.
25. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 1988;319:80-6.
26. Anticoagulants in acute myocardial infarction: results of a cooperative clinical trial. JAMA 1973;225:724-9.
27. Medical Research Council. Assessment of short-anticoagulant administration after cardiac infarction: report of the Working Party on Anticoagulant Therapy in Coronary Thrombosis to the Medical Research Council BMJ 1969;1:335-42.
28. Drapkin A, Merskey C. Anticoagulant therapy after acute myocardial infarction: relation of therapeutic benefit to patient's age, sex, and severity of infarction. JAMA 1972;222:541-8.
29. Smith P, Arnesen H, Holme I. The effect of warfarin on mortality and reinfarction after myocardial infarction. N Engl J Med 1990;323: 147-52.
30. Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis (ASPECT) Research Group. Effect of long-term oral anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction. Lancet 1994;343:499-503.
31. Cairns JA, Lewis HD Jr, Meade TW, Sutton GC, Theroux P. Antithrombotic agents in coronary artery disease. Chest 1995;108:Suppl:380S-400S.
32. Turpie AGG, Robinson JG, Doyle DJ, et al. Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction. N Engl J Med 1989;320:352-7.
33. Baker DW, Wright RF. Management of heart failure. IV. Anticoagulation for patients with heart failure due to left ventricular systolic dysfunction. JAMA 1994;272:1614-8.
34. Fuster V, Gersh BJ, Giuliani ER, Tajik AJ, Brandenburg RO, Frye RL. The natural history of idiopathic dilated cardiomyopathv Am J Cardiol 1981;47:525-31.